Logotype for The Simply Good Foods Company

The Simply Good Foods Company (SMPL) Q3 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for The Simply Good Foods Company

Q3 2026 earnings summary

9 Jul, 2026

Executive summary

  • Q3 2026 results exceeded internal expectations but remained below long-term goals, with all key financial metrics declining year-over-year due to early-stage turnaround efforts, execution challenges, and distribution declines for Atkins, partially offset by Quest and OWYN growth.

  • The company is focused on strengthening business economics, improving cost structure, margin, and productivity, and rebuilding brand investment, especially in marketing and consumer insights.

  • Significant non-cash impairment charges of $82 million in Q3 and $331 million year-to-date were recognized, mainly for Atkins and OWYN, due to declines in stock price and updated revenue projections.

  • Adjusted EBITDA for Q3 was $57.2 million, down 22.5% year-over-year, with a net loss of $52 million compared to net income of $41.1 million last year.

  • Progress is being made on cost structure and productivity initiatives, with a high single-digit price increase announced to offset inflation.

Financial highlights

  • Q3 2026 net sales were $357.0 million, down 6.3% year-over-year; gross margin declined 390 basis points to 32.5%.

  • Adjusted EBITDA dropped 22.5% to $57.2 million; adjusted EBITDA margin fell to 16.0%.

  • Net loss of $52.0 million in Q3, including an $82 million impairment charge; prior year was net income of $41.1 million.

  • Selling and marketing expenses rose 15.9% to $39.2 million in Q3.

  • Year-to-date net sales were $1,023.2 million, down 5.4% year-over-year; adjusted EBITDA for the period was $168.4 million, down 20.5%.

Outlook and guidance

  • FY2026 net sales expected at $1.345–$1.355 billion, a 6–7% decline year-over-year; gross margins projected to decline about 375 basis points.

  • Adjusted EBITDA forecasted at $220–$225 million, down 19–21% year-over-year.

  • Q4 2026 net sales expected at $322–$332 million, with adjusted EBITDA of $52–$57 million.

  • Margins are expected to remain under pressure until benefits from pricing actions and productivity initiatives are realized.

  • Capital expenditures for FY2026 expected at $20–$30 million, reflecting focused investment.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more